Pharmacogenomics Drives Lenalidomide Efficacy and MRD Kinetics in Mantle Cell Lymphoma after Autologous Transplantation: Results from the MCL0208 Multicenter, Phase III, Randomized Clinical Trial from the Fondazione Italiana Linfomi (FIL)

被引:1
|
作者
Ferrero, Simone
Grimaldi, Daniele
Arrigoni, Elena
Zaccaria, Gian Maria
Alessandria, Beatrice
Genuardi, Elisa
De Luca, Gabriele
Ghislieri, Marco
Di Rocco, Alice
Re, Alessandro
Stefoni, Vittorio
Cavallo, Federica
Boccomini, Carola
Balzarotti, Monica
Zilioli, Vittorio Ruggero
Maria, Gomes Da Silva
Arcaini, Luca
Molinari, Anna Lia
Ballerini, Filippo
Ferreri, Andres Jm
Puccini, Benedetta
Palumbo, Giuseppe A.
Galimberti, Sara
Cortelazzo, Sergio
Di Paolo, Antonello
Ladetto, Marco
机构
关键词
D O I
10.1182/blood-2020-134875
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 42 条
  • [21] A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial
    Bomben, Riccardo
    Ferrero, Simone
    D'Agaro, Tiziana
    Dal Bo, Michele
    Re, Alessandro
    Evangelista, Andrea
    Carella, Angelo Michele
    Zamo, Alberto
    Vitolo, Umberto
    Omede, Paola
    Rusconi, Chiara
    Arcaini, Luca
    Rigacci, Luigi
    Luminari, Stefano
    Piccin, Andrea
    Liu, Delong
    Wiestner, Adrian
    Gaidano, Gianluca
    Cortelazzo, Sergio
    Ladetto, Marco
    Gattei, Valter
    HAEMATOLOGICA, 2018, 103 (05) : 849 - 856
  • [22] Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
    Ladetto, M.
    Tavarozzi, R.
    Zanni, M.
    Evangelista, A.
    Ferrero, S.
    Tucci, A.
    Botto, B.
    Bolis, S.
    Volpetti, S.
    Zilioli, V. R.
    Puccini, B.
    Arcari, A.
    Pavone, V.
    Gaidano, G.
    Corradini, P.
    Tani, M.
    Cavallo, F.
    Milone, G.
    Ghiggi, C.
    Pinto, A.
    Pastore, D.
    Ferreri, A. J. M.
    Latte, G.
    Patti, C.
    Re, F.
    Benedetti, F.
    Luminari, S.
    Pennese, E.
    Bossi, E.
    Boccomini, C.
    Anastasia, A.
    Bottelli, C.
    Ciccone, G.
    Vitolo, U.
    ANNALS OF ONCOLOGY, 2024, 35 (01) : 118 - 129
  • [23] TP53 AND KMT2D MUTATIONS PREDICT PFS IN MCL PATIENTS TREATED WITH HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION: RESULTS FROM THE MCL0208 PHASE III TRIAL FROM FONDAZIONEITALIANA LINFOMI (FIL)
    Ferrero, S.
    Rossi, D.
    Bruscaggin, A.
    Ghione, P.
    Di Rocco, A.
    Spina, V.
    Stefoni, V.
    Ciccone, G.
    Barbero, D.
    Monitillo, L.
    Gomes da Silva, M.
    Santoro, A.
    Molinari, A.
    Ferreri, A.
    Piccin, A.
    Cortelazzo, S.
    Ladetto, M.
    Gaidano, G.
    HAEMATOLOGICA, 2016, 101 : S58 - S58
  • [24] Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial
    Genuardi, Elisa
    Romano, Greta
    Beccuti, Marco
    Alessandria, Beatrice
    Mannina, Donato
    Califano, Catello
    Rota Scalabrini, Delia
    Cortelazzo, Sergio
    Ladetto, Marco
    Ferrero, Simone
    Calogero, Raffaele A.
    Cordero, Francesca
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (02) : 378 - 381
  • [25] Early-Stage Follicular Lymphoma: Learnings from the Final Analysis of the Multicenter Phase II FIL (Fondazione Italiana Linfomi) "Miro" Trial, Combining Local Radiotherapy and MRD-Driven Immunotherapy
    Pulsoni, Alessandro
    Statistician, Maria Elena Tosti
    Ferrero, Simone
    Luminari, Stefano
    Dondi, Alessandra
    Liberati, Anna Marina
    Cenfra, Natalia
    Renzi, Daniela
    Zanni, Manuela
    Boccomini, Carola
    Ferreri, Andres Jose Maria
    Rattotti, Sara
    Zilioli, Vittorio Ruggero
    Bernuzzi, Patrizia
    Bolis, Silvia
    Musuraca, Gerardo
    Nassi, Luca
    Perrone, Tommasina
    Stelitano, Caterina
    Anastasia, Antonella
    Corradini, Paolo
    Partesotti, Giovanni
    Re, Francesca
    Cencini, Emanuele
    Mannarella, Clara
    Mannina, Donato
    Molinari, Anna Lia
    Tani, Monica
    Annechini, Giorgia
    Assanto, Giovanni Manfredi
    Grapulin, Lavinia
    Guarini, Anna
    Cavalli, Marzia
    De Novi, Lucia Anna
    Bomben, Riccardo
    Ciabatti, Elena
    Mantoan, Barbara
    Drandi, Daniela
    Della Starza, Irene
    Arcaini, Luca
    Ricardi, Umberto
    Gattei, Valter
    Galimberti, Sara
    Ladetto, Marco
    Foa, Robin
    Del Giudice, Ilaria
    BLOOD, 2023, 142
  • [26] Copanlisib in Combination with Rituximab and Bendamustine for Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: Results from the Phase II Multicenter Fil_Copa-Rb Trial from Fondazione Italiana Linfomi (FIL)
    Frascione, Pio Manlio Mirko
    Novo, Mattia
    Castellino, Alessia
    Marcheselli, Luigi
    Dattoli, Samantha Deianira
    Tucci, Alessandra
    Gini, Guido
    Tarantini, Giuseppe
    Mannina, Donato
    Arcari, Annalisa
    Martiniani, Roberta
    Scarpa, Elisabetta
    Marino, Dario
    Spina, Michele
    Gorgone, Ausilia Giuseppa
    Di Renzo, Nicola
    Mancuso, Salvatrice
    Petrucci, Luigi
    Tafuri, Agostino
    Vitolo, Umberto
    BLOOD, 2023, 142
  • [27] Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network
    Jiang, Linmiao
    Dreyling, Martin
    Hermine, Olivier
    Mansmann, Ulrich
    Walewski, Jan
    Ribrag, Vincent
    Thieblemont, Catherine
    Pott, Christiane
    Bachy, Emmanuel
    Feugier, Pierre
    Huebel, Kai
    Schumacher, Martin
    Hoster, Eva
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [28] B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)
    Balzarotti, Monica
    Brusamolino, Ercole
    Angelucci, Emanuele
    Carella, Angelo Michele
    Vitolo, Umberto
    Russo, Eleonora
    Congiu, Angelagiovanna
    Gotti, Manuel
    Massidda, Stefania
    Botto, Barbara
    Annechini, Giorgia
    Spina, Michele
    Re, Alessandro
    Zilioli, Vittorio Ruggero
    Merli, Francesco
    Salvi, Flavia
    Stelitano, Caterina
    Bonfichi, Maurizio
    Rodari, Marcello
    Murru, Roberta
    Magagnoli, Massimo
    Anastasia, Antonella
    Mazza, Rita
    Giordano, Laura
    Santoro, Armando
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2375 - 2381
  • [29] Rituximab Plus Bendamustine and Cytarabine (R-BAC) in Elderly Patients with Newly Diagnosed Mantle Cell Lymphoma: Long Term Follow-up and Mrd Results of a Phase 2 Study from the Fondazione Italiana Linfomi
    Tisi, Maria Chiara
    Nassi, Luca
    Patti, Caterina
    Spina, Michele
    Ferrero, Simone
    Tani, Monica
    Botto, Barbara
    Molinari, Anna Lia
    Puccini, Benedetta
    Cencini, Emanuele
    Di Rocco, Alice
    Chini, Claudio
    Ghiggi, Chiara
    Zambello, Renato
    Zanni, Manuela
    Sciarra, Roberta
    Ferrante, Martina
    Stelitano, Caterina
    Re, Alessandro
    Volpetti, Stefano
    Zilioli, Vittorio Ruggero
    Arcari, Annalisa
    Merli, Francesco
    Visco, Carlo
    BLOOD, 2021, 138
  • [30] PCR-Based Minimal Residual Disease (MRD) Detection Is a Strong Independent Outcome Predictor Also in Rituximab-Intensive Non-ASCT-Based Programs: Results From the ML17638 Multicenter Randomised Phase III Trial for Elderly Follicular Lymphoma (FL) Patients of the Fondazione Italiana Linfomi (FIL)
    Ladetto, Marco
    Lobetti-Bodoni, Chiara
    Mantoan, Barbara
    Evangelista, Andrea
    Boccomini, Carola
    Genuardi, Elisa
    Botto, Barbara
    Baldini, Luca
    Rossi, Giuseppe
    Pulsoni, Alessandro
    Di Raimondo, Francesco
    Rigacci, Luigi
    Pinto, Antonello
    Petrini, Mario
    Sacchi, Stefano
    Rota-Scalabrini, Delia
    Gugliotta, Luigi
    Fanin, Renato
    Gallamini, Andrea
    Parvis, Guido
    Specchia, Giorgina
    Musto, Pellegrino
    Olivero, Barbara
    Gamba, Enrica
    Ciccone, Giovannino
    Vitolo, Umberto
    BLOOD, 2012, 120 (21)